It doesn’t seem to matter what time of day or night you take your blood pressure medication, a new study finds. The results of a randomized trial of more than 21,000 patients with high blood pressure who were followed for over five years show that protection against heart attack, stroke and vascular death is not… read on > read on >
It’s safe to say that when searching for somewhere to live most people prefer open, airy spaces over dark and dingy ones. Now, new research suggests why: Homes filled with lots of natural light makes for happier residents. “We sought to explore the relationship between natural light and emotional well-being in residential indoor spaces,” explained… read on > read on >
U.S. doctors administered more than 150,000 doses of useless monoclonal antibody treatments to COVID-19 patients early this year, spending loads of cash on therapies that had been deemed of no benefit, a new study has found. The U.S. Food and Drug Administration deauthorized the use of two COVID monoclonal antibody treatments in January, after it… read on > read on >
The days of getting free COVID-19 tests by mail are drawing to a close. The Biden administration plans to stop sending test kits to Americans on Sept. 2 in order to reserve remaining tests for a fall surge. Lack of funding from Congress is the reason for the change, NBC News reported, citing an unnamed… read on > read on >
Recent years have seen several high-profile cases of doctors sexually abusing young patients. Now the American Academy of Pediatrics (AAP) is issuing new recommendations aimed at prevention. Medical visits are usually a safe place for children and teenagers, but when abuse does happen, it is an egregious violation. One reason, the AAP says, is because… read on > read on >
Roughly six months after it shut down its baby formula plant in Michigan, Abbott Laboratories said it plans to begin making Similac again. The baby formula will be the latest to restart production after Abbott’s specialty formulas, including EleCare, resumed production a couple of months ago. In February, Abbott closed its plant and recalled some… read on > read on >
MONDAY, Aug. 29, 2022 (American Heart Association News) — People with high blood pressure may be at higher risk for developing cardiovascular disease and diabetes if they work frequent night shifts, new research suggests. The higher risk was more pronounced among people who also slept too much or too little when they weren’t working, according… read on > read on >
In a finding that proves convenience is key when it comes to sticking to a medication regimen, new research shows that combining three heart drugs into one “polypill” slashes the risk of dying from a second heart attack by 33%. “The results of the SECURE study show that for the first time that the polypill,… read on > read on >
MONDAY, Aug. 29, 2022 Katherine Sanden drove over 1,400 miles, from California to Nebraska, to care for her beloved uncle after he was diagnosed with Alzheimer’s in November 2020, but seeing him after years apart was more devastating than she could have ever imagined. Like Sanden, many family caregivers are thrown into the deep end… read on > read on >
Labor shortages at Teva Pharmaceuticals have made Adderall, a widely used attention-deficit/hyperactivity disorder (ADHD) drug, hard to find in some drugstores. But the U.S. Food and Drug Administration noted that there’s no overall shortage of ADHD medications. Only Teva is reporting supply problems, FDA spokeswomen Cherie Duvall-Jones told NBC News. “Teva Pharmaceuticals, the maker for… read on > read on >
